Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released

Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine...